Fintech targeted by climate skeptics banks $37 million from likes of UBS, CommerzVentures
Swedish climate fintech Doconomy told CNBC it’s raised $36.9 million in a Series B round co-led by the venture arms of UBS and CommerzBank.
L’Oreal says it’s working on a form of bioprinted skin that can actually ‘feel’
L’Oreal says it is working with start-ups and research institutions to develop bioprinted skin that can actually “feel.”
South Korean tech conglomerate SK Inc. surges 16% after chair’s $1 billion divorce settlement
SK Inc. is one of Korea’s largest conglomerates and is the holding firm for SK Hynix, one of the world’s biggest memory chip firms.
BlackRock-backed fintech Trustly says IPO still at least one year out even as profits jump 51%
Johan Tjarnberg, CEO of Trustly, told CNBC his firm still needs time to prove the value of its open banking tech to investors before going public.
UBS overhauls wealth management leadership in wider board shake-up
The new appointments provide an important signal on the future direction of the bank as it tees up a replacement for outgoing CEO Sergio Ermotti.
South Africa’s ruling ANC set to lose majority in pivotal vote, early results show
Early indications from 17.54% of polls show the ANC gaining 42.95% of support, with the Democratic Alliance (DA) wresting 25.24% of votes.
Orange juice prices are going through the roof — forcing some makers to consider alternative fruits
Orange juice prices have climbed to fresh all-time highs amid persistent supply constraints, forcing some makers to consider alternative fruits.
CNBC Daily Open: Dow drops, Nvidia couldn’t save Nasdaq
S&P 500 ends three-day winning streak, Salesforce plunges on revenue and forecast and Peltz sells entire Disney stake.
Psychology expert shares her No. 1 tip on how to deprioritize work and live a purposeful life
Jodi Wellman, a positive psychology expert, was an executive leader for 17 years but realized that achieving the pinnacle of success wasn’t bringing her any joy.
Nutritional needs are ‘shifting’ amid rise of weight loss drugs, says Nestle CEO
Consumers’ nutritional needs are “shifting” amid the rise of weight loss drugs, which is an opportunity for food companies, Nestle CEO Mark Schneider said.
